Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome–like skeletal defects induced by Pdk1 or Cbp mutations in mice
Authors:
- Jae-Hyuck ShimJSJae-Hyuck Shim
- Matthew B. GreenblattMGMatthew B. Greenblatt
- Anju SinghASAnju Singh
- Nicholas BradyNBNicholas Brady
- Dorothy HuDHDorothy Hu
- Rebecca DrappRDRebecca Drapp
- Wataru OgawaWOWataru Ogawa
- Masato KasugaMKMasato Kasuga
- Tetsuo NodaTNTetsuo Noda
- Sang-Hwa YangSYSang-Hwa Yang
- Sang-Kyou LeeSLSang-Kyou Lee
- Vivienne I. RebelVRVivienne I. Rebel
Open Access
- 3 January 2012
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 122 (1) , 91-106
Abstract
Mutations in the coactivator CREB-binding protein (CBP) are a major cause of the human skeletal dysplasia Rubinstein-Taybi syndrome (RTS); however, the mechanism by which these mutations affect skeletal mineralization and patterning is unknown. Here, we report the identification of 3-phosphoinositide-dependent kinase 1 (PDK1) as a key regulator of CBP activity and demonstrate that its functions map to both osteoprogenitor cells and mature osteoblasts. In osteoblasts, PDK1 activated the CREB/CBP complex, which in turn controlled runt-related transcription factor 2 (RUNX2) activation and expression of bone morphogenetic protein 2 (BMP2). These pathways also operated in vivo, as evidenced by recapitulation of RTS spectrum phenotypes with osteoblast-specific Pdk1 deletion in mice (Pdk1osx mice) and by the genetic interactions observed in mice heterozygous for both osteoblast-specific Pdk1 deletion and either Runx2 or Creb deletion. Finally, treatment of Pdk1osx and Cbp+/– embryos with BMPs in utero partially reversed their skeletal anomalies at birth. These findings illustrate the in vivo function of the PDK1-AKT-CREB/CBP pathway in bone formation and provide proof of principle for in utero growth factor supplementation as a potential therapy for skeletal dysplasias.Keywords
This publication has 66 references indexed in Scilit:
- Transcriptional Regulation of BMP2 Expression by the PTH-CREB Signaling Pathway in OsteoblastsPLOS ONE, 2011
- The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in miceJournal of Clinical Investigation, 2010
- Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy MetabolismCell, 2010
- Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body CompositionCell, 2010
- Selective Signaling by Akt2 Promotes Bone Morphogenetic Protein 2-Mediated Osteoblast DifferentiationMolecular and Cellular Biology, 2010
- Akt promotes BMP2-mediated osteoblast differentiation and bone developmentJournal of Cell Science, 2009
- Endochondral ossification is required for haematopoietic stem-cell niche formationNature, 2008
- Akt1 in Osteoblasts and Osteoclasts Controls Bone RemodelingPLOS ONE, 2007
- Autoregulation of Mouse BMP-2 Gene Transcription Is Directed by the Proximal Promoter ElementBiochemical and Biophysical Research Communications, 2001
- Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red STeratology, 1980